Two case reports of mesenteric and retroperitoneal actinomycosis and a narrative review of the relevant literature

Authors

  • Orestis Ioannidis 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki,
  • Savvas Symeonidis 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Nikolaos Ouzounidis 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Vasilis Foutsitzis 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Elissavet Anestiadou 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Panagiotis Christidis 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Lydia Loutzidou 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Vasiliki Fesatidou 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Ourania Kerasidou 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Konstantinos Tsalis 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
  • Stamatios Aggelopoulos 4th Academic Department of Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece

DOI:

https://doi.org/10.15386/mpr-2073

Keywords:

actinomyces, actinomycosis, retroperitoneal, mesenteric, abdominal, mesocolic mass

Abstract

Introduction. Actinomycosis is an uncommon subacute or chronic suppurative bacterial granulomatous infectious disease with clinical heterogeneity. The majority of actinomycosis cases were of extra-abdominal origin, with oro-cervico-facial cases representing 55%, abdominopelvic representing 20%, and thoracic representing 15% of total reports. Currently, abdominal actinomycosis incidence is approximately 1 case per 119,000 people, being found three times more frequently among males. We report two rare clinical presentations of abdominal actinomycosis affecting the mesentery and the retroperitoneum, respectively.

Case Report 1. A 58-year-old Caucasian male presented to our clinic with abdominal pain in the right upper quadrant. Pre-operative evaluation, although inconclusive, showed a mesocolic mass infiltrating the right and transverse colon. The patient underwent exploratory laparotomy. After partial resection of the mass, the histopathology report demonstrated mesenteric actinomycosis.

Case Report 2. A 40-year-old Caucasian male presented to our clinic complaining about a mucopurulent material from an orifice at the right inguinal region. After appropriate work-up, a large abdominopelvic, stellate mass (75 x 22.8 mm) in the retroperitoneum was revealed. Surgery along with the appropriate antibiotics was used to treat the patient.

Conclusion. Preoperative suspicion and diagnosis of actinomycosis are very challenging, with a high rate of misdiagnosis often resulting in delayed treatment. Our case reports highlight that abdominal actinomycosis should always be part of differential diagnosis, especially when there is involvement of multiple organs. The gold standard treatment of actinomycosis is surgical excision with prolonged antibiotic treatment.

Downloads

Published

2023-10-24

How to Cite

1.
Ioannidis O, Symeonidis S, Ouzounidis N, Foutsitzis V, Anestiadou E, Christidis P, Loutzidou L, Fesatidou V, Kerasidou O, Tsalis K, Aggelopoulos S. Two case reports of mesenteric and retroperitoneal actinomycosis and a narrative review of the relevant literature. Medicine and Pharmacy Reports [Internet]. 2023 Oct. 24 [cited 2025 Jun. 13];96(4):441-6. Available from: https://medpharmareports.com/index.php/mpr/article/view/2073

Issue

Section

Case Report